Cita APA

Babashov, V., Begen, M., Mangel, J., & Zaric, G. (2017). Economic evaluation of brentuximab vedotin for persistent Hodgkin lymphoma. Curr Oncol.

Citación estilo Chicago

Babashov, V., M.A Begen, J. Mangel, y G.S Zaric. "Economic Evaluation of Brentuximab Vedotin for Persistent Hodgkin Lymphoma." Curr Oncol 2017.

Cita MLA

Babashov, V., M.A Begen, J. Mangel, y G.S Zaric. "Economic Evaluation of Brentuximab Vedotin for Persistent Hodgkin Lymphoma." Curr Oncol 2017.